News for Regeneron Pharmaceuticals, Inc. (REGN34.SA)

Published at

Jun 11, 2025 2:01 PM

by thestockmarketwatch.com

mixed

mixed

Stock Market Today: S&P 500 Approaches Record High as US-China Trade Talks Progress

U.S. stock futures are pointing to a mixed open on Wednesday, June 11, 2025, as investors digest the latest developments in U.S.-China trade negotiations and

VRA PTX.DE PLTR NVDC34.SA NVDA.MX NVDA.BA NVDA NVD.DE CHWY.MX CHWY 0A7R.L TSLAD.BA TSLAC.BA TSLA34.SA TSLA.MX TSLA TL0.DE REGN34.SA REGN.MX REGN FMC1.DE F.SW F.MX F 0R2M.L

Read more →
Published at

Jun 3, 2025 2:49 AM

by insidermonkey.com

neutral

neutral

Regeneron Pharmaceuticals, Inc. (REGN)’s Weight-Loss Drug Aids Muscle Preservation in Wegovy Users

Regeneron Pharmaceuticals, Inc.

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

Jun 2, 2025 6:30 PM

by gurufocus.com

neutral

neutral

Regeneron Pharmaceuticals (REGN): Citigroup Lowers Price Target to $650 | REGN Stock News

On June 2, 2025, Citigroup analyst Geoff Meacham maintained his 'Buy' rating for Regeneron Pharmaceuticals (REGN), while also lowering the price target from $70

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

Jun 2, 2025 5:02 PM

by gurufocus.com

neutral

neutral

Regeneron Pharmaceuticals (REGN): Analyst Maintains Rating but Lowers Price Target | REGN Stock News

On June 2, 2025, BMO Capital analyst Evan David Seigerman made significant adjustments to their assessment of Regeneron Pharmaceuticals (REGN), a leading biotec

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

Jun 2, 2025 4:58 PM

by gurufocus.com

positive

positive

Regeneron (REGN) Reports Promising Obesity Treatment Trial Results

Key Highlights: Regeneron Pharmaceuticals (REGN) reports promising interim results in obesity treatment trials. Analysts forecast a potential upside of 5

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

Jun 2, 2025 4:30 PM

by gurufocus.com

mixed

mixed

Regeneron Pharmaceuticals (REGN) Price Target Lowered by Morgan Stanley | REGN Stock News

Regeneron Pharmaceuticals (REGN) is in the spotlight following a notable update from Morgan Stanley. On June 2, 2025, the investment firm adjusted its price tar

REGN34.SA REGN.MX REGN 0R2M.L MSCL.SN

Read more →
Published at

Jun 2, 2025 4:23 PM

by gurufocus.com

positive

positive

Regeneron Pharmaceuticals Inc (REGN) Announces Strategic Licensing Agreement with Hansoh Pharma | REGN stock news

Summary Regeneron Pharmaceuticals Inc (REGN) has announced a strategic in-licensing agreement with Hansoh Pharmaceuticals Group Company Limited to acquire exclu

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

Jun 2, 2025 4:19 PM

by gurufocus.com

neutral

neutral

Regeneron (REGN) Faces Challenges Amid Mixed COPD Trial Results | REGN Stock News

Regeneron (REGN) experienced a setback when its partner, Sanofi, announced mixed outcomes from the Phase 3 trials of itepekimab, a treatment targeting COPD. Thi

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

Jun 2, 2025 3:00 PM

by gurufocus.com

neutral

neutral

Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic In-Licensing of Novel Dual GLP-1/GIP Receptor Agonist

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced stages of clinical development in China P

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

Jun 2, 2025 2:45 PM

by gurufocus.com

positive

positive

Regeneron (REGN) Secures Rights for Promising GLP-1/GIP Drug | REGN Stock News

Regeneron Pharmaceuticals (REGN) has entered into a strategic agreement with Hansoh Pharmaceuticals to acquire exclusive rights for the development and commerci

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

Jun 2, 2025 2:10 PM

by gurufocus.com

positive

positive

Regeneron Pharmaceuticals Inc (REGN) Announces Promising Interim Results from Phase 2 COURAGE Trial | REGN stock news

Summary Regeneron Pharmaceuticals Inc (REGN) has released interim results from its Phase 2 COURAGE trial, which explores the efficacy of combining semaglutide w

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

May 31, 2025 2:04 PM

by benzinga.com

mixed

mixed

Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

SPRO PTX.DE PLTR NVDAD.BA NVDAC.BA NVDA.MI NVDA NPCE 0A7R.L ULTA.MX ULTA U1LT34.SA REGN34.SA REGN.MX REGN MRVL1.MX MRVL 0UBI.L 0R2M.L 0LIB.L 2840.HK

Read more →
Published at

May 30, 2025 3:10 PM

by benzinga.com

mixed

mixed

Elastic, Gap, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Cooper Companies (NASDAQ:COO), American Eagle Outfitters (NYSE:AEO)

U.S. stock futures were lower this morning, with the Dow futures falling around 0.1% on Friday. Shares of Elastic N.V. ESTC fell sharply in today's pre-market ...

ESTC E2ST34.SA 3E1.DE REGN34.SA REGN.MX REGN NTAP NTA.DE N1TA34.SA GPSI34.SA GPS.MX GPS GAP.DE COO.MX COO C1OO34.SA AEO 0R2M.L 0K6F.L 0ITS.L 0I3I.L

Read more →
Published at

May 30, 2025 1:15 PM

by rttnews.com

mixed

mixed

Pre-market Movers: BSLK, BMGL, RRGB, LZMH, MDCX…

California-based Bolt Projects Holdings, Inc. (BSLK) is up over 114 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

VVPR PATH P2AT34.SA BGI SPRO NPCE IQST INO.MX INO GPSI34.SA GPS.MX GPS GAP.DE 0ITS.L 0A43.L RRGB REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

May 27, 2025 6:51 PM

by manilatimes.net

positive

positive

23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC

**media[638399]**

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

May 27, 2025 5:30 PM

by gurufocus.com

positive

positive

Regeneron Pharmaceuticals (REGN) Sees Steady Analyst Outlook by RBC Capital | REGN Stock News

Regeneron Pharmaceuticals (REGN) continues to garner confidence from analysts, as RBC Capital, led by analyst Brian Abrahams, reaffirms their support with an "O

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

May 23, 2025 2:04 AM

by gurufocus.com

neutral

neutral

Regeneron Pharmaceuticals Inc (REGN) Announces Promising Phase 1b Trial Results for Linvoseltamab Combinations in Multiple Myeloma | REGN stock news

Summary Regeneron Pharmaceuticals Inc (REGN) has released initial results from its Phase 1b LINKER-MM2 trial, which evaluates the efficacy of linvoseltamab in c

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

May 22, 2025 11:19 PM

by manilatimes.net

negative

negative

Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma

**media[634758]**

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

May 22, 2025 4:18 PM

by insidermonkey.com

positive

positive

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Made A “Very Smart Deal,” Says Jim Cramer

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.

REGN34.SA REGN.MX REGN 0R2M.L

Read more →
Published at

May 22, 2025 4:18 PM

by finance.yahoo.com

positive

positive

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Made A “Very Smart Deal,” Says Jim Cramer

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other stocks that Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the Street, […]

REGN34.SA REGN.MX REGN 0R2M.L

Read more →